Skip to content

A multicenter prospective cohort study on the diagnostic efficacy and criteria of transvaginal ultrasound three-dimensional hysterosalpingo-contrast sonography and laparoscopy for tubal patency in infertile women

A multicenter prospective cohort study on the diagnostic efficacy and criteria of transvaginal ultrasound three-dimensional hysterosalpingo-contrast sonography and laparoscopy for tubal patency in infertile women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010731
Enrollment
Unknown
Registered
2017-02-26
Start date
2017-03-11
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Sponsors

Guangzhou General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Infertility patients with suspected tubal obstruction; 2. The history of lower abdominal surgery (appendix, cesarean section), pelvic inflammatory disease, endometriosis; 3. effect of sterilization, recanalization, or other postoperative and drug curative effect evaluation after treatment; 4. Laparoscopic diagnosis of intrauterine adhesions; 5. Uterine malformation or uterine cavity lesions; 6. Iodine allergy.

Exclusion criteria

Exclusion criteria: 1. acute inflammation of the reproductive organs, Serious trichomonas or Candida vaginitis; 2. Cervical ectropio or the cervical secretion more; 3. menstrual phase or abnormaluterine bleeding; 4. Pelvic active tuberculose; 5. The cervix or uterus suspected malignant lesions; 6. Contrast allergy.

Design outcomes

Primary

MeasureTime frame
tubal were unobstructed;tubal were completely obstructed;tubal were partially obstructed;

Secondary

MeasureTime frame
contrast agent surrounding around ovary;contrast agent surrounding around pelvic cavity;the pressure of injecting contrast agents;

Countries

China

Contacts

Public ContactSha Sha Wang

Guangzhou General Hospital

wss878333@163.com+86 13076878333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026